Melanoma antigen-specific effector T cell cytokine secretion patterns in patients treated with ipilimumab

BACKGROUND: In a previously reported study, patients with regionally advanced melanoma were treated with neoadjuvant ipilimumab (ipi) (Tarhini in PLoS ONE 9(2): e87705, 3). Significant changes in circulating myeloid derived suppressor cells (MDSC), regulatory T cells (Treg) and peptide specific type...

Descripción completa

Detalles Bibliográficos
Autores principales: Najjar, Yana G., Ding, Fei, Lin, Yan, VanderWeele, Robert, Butterfield, Lisa H., Tarhini, Ahmad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319167/
https://www.ncbi.nlm.nih.gov/pubmed/28222797
http://dx.doi.org/10.1186/s12967-017-1140-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319167/
https://www.ncbi.nlm.nih.gov/pubmed/28222797
http://dx.doi.org/10.1186/s12967-017-1140-9

Ejemplares similares